From: Association of night eating habits with metabolic syndrome and its components: a longitudinal study
Total | ||||
---|---|---|---|---|
Those with neither habit | Those with a single habit of “dinner immediately before bed” (≥3 times per week) | Those with a single habit of “snacks after dinner” (≥3 times per week) | Those with both habits | |
Metabolic syndrome | n = 7287 | |||
Number of participants | 249/4063 | 120/1758 | 58/859 | 51/607 |
Model 1a | 1.00 | 1.14 (0.90–1.44) | 1.12 (0.83–1.51) | 1.43 (1.04–1.96) |
Model 2b | 1.00 | 1.10 (0.86–1.41) | 1.13 (0.83–1.54) | 1.33 (0.95–1.86) |
Abdominal obesity | n = 5780 | |||
Number of participants | 342/3212 | 148/1485 | 87/652 | 58/431 |
Model 1 | 1.00 | 1.20 (0.97–1.49) | 1.18 (0.91–1.52) | 1.52 (1.12–2.07) |
Model 2 | 1.00 | 1.15 (0.92–1.45) | 1.19 (0.91–1.55) | 1.41 (1.03–1.95) |
Model 3c | 1.00 | 1.16 (0.93–1.47) | 1.19 (0.91–1.55) | 1.42 (1.03–1.97) |
Obesity | n = 6225 | |||
Number of participants | 204/3542 | 128/1489 | 51/747 | 63/447 |
Model 1 | 1.00 | 1.32 (1.04–1.68) | 1.30 (0.94–1.79) | 2.47 (1.82–3.35) |
Model 2 | 1.00 | 1.31 (1.01–1.69) | 1.32 (0.95–1.84) | 2.34 (1.69–3.23) |
Model 3c | 1.00 | 1.33 (1.02–1.71) | 1.32 (0.95–1.84) | 2.37 (1.71–3.29) |
Hypertension | n = 6074 | |||
Number of participants | 512/3368 | 252/1431 | 103/749 | 80/526 |
Model 1 | 1.00 | 1.04 (0.87–1.23) | 0.95 (0.75–1.19) | 0.92 (0.71–1.19) |
Model 2 | 1.00 | 0.97 (0.81–1.17) | 0.95 (0.74–1.21) | 0.89 (0.68–1.16) |
Model 3d | 1.00 | 0.98 (0.82–1.18) | 0.92 (0.72–1.17) | 0.78 (0.59–1.03) |
Dyslipidemia | n = 6177 | |||
Number of participants | 447/3462 | 239/1450 | 96/763 | 102/502 |
Model 1 | 1.00 | 1.16 (0.97–1.39) | 1.04 (0.82–1.31) | 1.63 (1.28–2.08) |
Model 2 | 1.00 | 1.20 (0.99–1.45) | 1.07 (0.83–1.37) | 1.61 (1.25–2.09) |
Model 3e | 1.00 | 1.18 (0.97–1.43) | 1.03 (0.80–1.33) | 1.49 (1.14–1.94) |
Hyper triglyceridemia | n = 6605 | |||
Number of participants | 286/3694 | 176/1535 | 64/833 | 71/543 |
Model 1 | 1.00 | 1.21 (0.98–1.49) | 1.11 (0.83–1.47) | 1.58 (1.19–2.09) |
Model 2 | 1.00 | 1.15 (0.92–1.42) | 1.16 (0.87–1.56) | 1.44 (1.07–1.95) |
Model 3e | 1.00 | 1.13 (0.91–1.41) | 1.11 (0.83–1.49) | 1.35 (0.99–1.84) |
Low HDL cholesterolemia | n = 7750 | |||
Number of participants | 125/4246 | 62/1922 | 27/917 | 32/665 |
Model 1 | 1.00 | 1.13 (0.82–1.56) | 0.99 (0.65–1.52) | 1.70 (1.14–2.53) |
Model 2 | 1.00 | 1.27 (0.91–1.79) | 1.07 (0.69–1.67) | 1.63 (1.06–2.51) |
Model 3e | 1.00 | 1.19 (0.84–1.68) | 0.99 (0.64–1.55) | 1.36 (0.88–2.11) |
Hyperglycemia | n = 5717 | |||
Number of participants | 509/3194 | 198/1386 | 106/669 | 79/468 |
Model 1 | 1.00 | 0.96 (0.80–1.15) | 0.97 (0.77–1.22) | 1.16 (0.89–1.51) |
Model 2 | 1.00 | 0.98 (0.81–1.19) | 0.92 (0.72–1.18) | 1.13 (0.86–1.49) |
Model 3f | 1.00 | 0.99 (0.82–1.20) | 0.90 (0.70–1.15) | 1.06 (0.80–1.40) |